Why Celestica Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
AVITA Medical Inc RCEL
$4.40
▼ -2.00%
($-0.09)
📅 Earnings This Week
Open
$4.44
Prev Close
$4.49
Day Range
$4.24 – $4.57
52W Range
$3.22 – $7.12
Market Cap
$135.42M
Beta
1.85
EPS (TTM)
$-1.57
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2012-03-18 |
| Shares Out. | 30,780,000 |
| Website | avitamedical.com/ ↗ |
| Phone | 13023513367 |
| Employees | 226 |
| Revenue | $19.3M |
| Gross Profit | $15.7M |
| Net Income | -$10.6M |
| Free Cash Flow | -$31.8M |
| Total Assets | $51.5M |
| Total Liabilities | $74.7M |
| Equity | -$23.2M |
About AVITA Medical Inc
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
AVITA Medical Inc is a publicly traded company under the ticker symbol RCEL on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-07-01)